Roof Advisory Group’s Pfizer PFE Stock Holding History

Roof Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$759K	Buy	18,468 +1,331	+8%	+$52.9K	0.44%	27
2019 Q1	$691K	Buy	17,137 +141	+0.8%	+$5.65K	0.45%	29
2018 Q4	$704K	Buy	+16,996	New	+$706K	0.5%	31
2018 Q3	–	Sell	-201,359	Closed	-$6.93M	–	36
2018 Q2	$6.93M	Buy	201,359 +6,495	+3%	+$222K	3.79%	7
2018 Q1	$6.56M	Buy	194,864 +6,632	+4%	+$228K	3.31%	9
2017 Q4	$6.47M	Buy	+188,232	New	+$6.42M	3.68%	8

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Roof Advisory Group's PFE Position: Q2 2019 in Review

Roof Advisory Group increased its Pfizer (PFE) stake by 7.8% in Q2 2019, buying an estimated $52.9K and bringing the position to 18,468 shares worth $759K. The position accounts for 0.44% of the portfolio, ranked #27.

Roof Advisory Group first reported a position in PFE in Q4 2017 and has held it in 6 quarters since. The position peaked at $6.93M in Q2 2018. 2,377 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

Roof Advisory Group held 18,468 shares of Pfizer worth $759K as of Q2 2019.
Roof Advisory Group bought 1,331 Pfizer shares in Q2 2019, an estimated $52.9K.
Pfizer made up 0.44% of Roof Advisory Group's portfolio in Q2 2019, its #27 holding.
Roof Advisory Group first reported a position in Pfizer in Q4 2017 and has held it in 6 quarters since.
Roof Advisory Group's Pfizer position peaked at $6.93M in Q2 2018.
2,377 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Roof Advisory Group's 13F filing for Q2 2019, filed 8 Aug 2019.